Similarly, GEP of CD19+-selected B-cells from primary DLBCL patient samples were enriched for the DC profile when compared to a normal human GCB centroblast data set (Supplementary Fig. 7b). This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.